About Caring4Cancer

 
Caring4Cancer's mission is to provide a complete source of knowledge and support for people with cancer, empowering them with the expertise, strength and hope they need to live their lives to the fullest. Caring4Cancer combines a virtual encyclopedia of cancer information with a collection of powerful tools that help patients take an active role in managing their disease. Our world-renowned Oncology Advisory Board reviews our content for accuracy and timeliness.

At Caring4Cancer, you can:

  • Shape the content to match your specific cancer type, diagnosis, and phase of treatment or recovery
  • Interact with other patients and experts through our message boards
  • Keep track of your symptoms, treatments, and appointments with a secure Patient Health Record and Symptom Tracker
  • View online videos right in your doctor’s office or in the comfort of your own home
  • Sign up for e-newsletters tailored to your interests and needs.
  • Create your own personal web page where you can keep a personal journal, exchange messages of encouragement, share pictures, and more.

Hundreds of oncology practices are now prescribing Caring4Cancer’s educational and interactive tools to their patients, just as they prescribe medication or therapy.However, the content at Caring4Cancer is not intended to be a substitute for professional medical advice, diagnosis, or treatment. For information on how to contact us, please click here.

Latest Cancer News
U.S. Study Confirms Effectiveness of Stereotactic Radiotherapy for Early-stage Lung Cancer

March 18, 2010 — Researchers affiliated with a Phase II North American multicenter study have reported that sterotactic radiotherapy for Stage TI-II non–small cell lung cancer (NSCLC) results in a three-year survival rate of 56% in medically inoperable patients. The details of this study were published in the March 17, 2010 issue of the Journal of the American Medical Association.

Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer

March 18, 2010 — Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results of a 15-year study presented at 2010 American Society of Clinical Oncology Genitourinary Symposium March 5-7 in San Francisco.

Low-income Women Experience Delayed Follow-up of Abnormal Mammograms

March 18, 2010 — Researchers affiliated with Harvard University and the National Breast and Cervical Cancer Early Detection Program (BCCEDP) have reported that there is a significant delay in follow-up diagnostic tests and treatment following a positive mammogram in one-third of low-income women participating in this program. The details of this study were published early online in the Archives of Internal Medicine on March 16, 2010.

Select news items provided by Reuters Health